World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
43
Citations
6415
World Ranking
7447
National Ranking
3209

Overview

Mark J. Niciu is affiliated with the University of Iowa in the United States. Their primary fields of study include Neuroscience and Medicine, with significant contributions also made in subfields such as Neurology, Pharmacology, Cognitive Neuroscience, Biological Psychiatry, and Cardiology and Cardiovascular Medicine.

Their research covers a range of topics centered on the treatment of major depression and brain function, including:

  • Treatment of Major Depression
  • Tryptophan and brain disorders
  • Functional Brain Connectivity Studies
  • Heart Rate Variability and Autonomic Control
  • Transcranial Magnetic Stimulation Studies
  • Neuroscience and Neuropharmacology Research
  • Health, Environment, Cognitive Aging

Mark J. Niciu has authored several recent papers, which highlight both clinical and neurophysiological aspects of brain research:

  • National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder, 2023, Journal of Affective Disorders
  • Transcranial magnetic stimulation induces heart rate decelerations independent of treatment outcome, 2023, Brain Stimulation
  • (Es)Ketamine for Suicidal Ideation and Behavior: Clinical Efficacy, 2022, Chronic Stress
  • Biomarkers of ketamine's antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology, 2021, Chronic Stress
  • Rigor and reproducibility in human brain organoid research: Where we are and where we need to go, 2024, Stem Cell Reports

Frequent publication venues for Mark J. Niciu include:

  • Brain Stimulation
  • Chronic Stress
  • Biological Psychiatry
  • Stem Cell Reports
  • Journal of Affective Disorders

The scientist collaborates with a number of colleagues, notably:

  • Alexandra Alario
  • Nicholas T. Trapp
  • Krishnan Padmanabhan
  • Daifeng Wang
  • Jason L. Stein

Best Publications

  • Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

    Marc S. Lener;Mark J. Niciu;Elizabeth D. Ballard;Minkyung Park

  • Overview of glutamatergic neurotransmission in the nervous system.

    Mark J. Niciu;Benjamin Kelmendi;Gerard Sanacora

  • Do the dissociative side effects of ketamine mediate its antidepressant effects

    David A. Luckenbaugh;Mark J. Niciu;Dawn F. Ionescu;Neal M. Nolan

  • Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

    Elizabeth D. Ballard;Dawn F. Ionescu;Jennifer L. Vande Voort;Mark J. Niciu

  • NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia

    Alan Anticevic;Mark Gancsos;John D. Murray;Grega Repovs

  • Neural correlates of change in major depressive disorder anhedonia following open-label ketamine

    Níall Lally;Níall Lally;Allison C Nugent;David A Luckenbaugh;Mark J Niciu

  • The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.

    Douglas L. Boggs;Toral Surti;Aarti Gupta;Swapnil Gupta

  • Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.

    Nicolas D. Iadarola;Mark J. Niciu;Erica M. Richards;Jennifer L. Vande Voort

  • Clinical predictors of ketamine response in treatment-resistant major depression.

    Mark J. Niciu;David A. Luckenbaugh;Dawn F. Ionescu;Sara Guevara

  • Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

    Mark J. Niciu;Dawn F. Ionescu;Erica M. Richards;Carlos A. Zarate

  • Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds

    Mark J. Niciu;Ioline D. Henter;David A. Luckenbaugh;Carlos A. Zarate

  • PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects

    Erica M. Richards;Paolo Zanotti-Fregonara;Masahiro Fujita;Laura Newman

  • Neurobiology of anxious depression: a review.

    Dawn F. Ionescu;Mark J. Niciu;Daniel C. Mathews;Erica M. Richards

  • Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials

    Elizabeth D. Ballard;Kathleen Wills;Níall Lally;Erica M. Richards

  • Defining anxious depression: a review of the literature

    Dawn F Ionescu;Mark J Niciu;Ioline D Henter;Carlos A Zarate

  • Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.

    Mark J. Niciu;Bridget J. Shovestul;Brittany A. Jaso;Cristan Farmer

  • Effect of baseline anxious depression on initial and sustained antidepressant response to Ketamine

    Dawn F. Ionescu;David A. Luckenbaugh;Mark J. Niciu;Erica M. Richards

  • A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.

    Dawn F Ionescu;David A Luckenbaugh;Mark J Niciu;Erica M Richards

  • Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment.

    M.J. Niciu;X.-M. Ma;R. El Meskini;R. El Meskini;G.V. Ronnett

  • Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder.

    Brittany A. Jaso;Mark J. Niciu;Nicolas D. Iadarola;Niall Lally

Frequent Co-Authors

Elizabeth D. Ballard
Elizabeth D. Ballard National Institutes of Health
Maura L. Furey
Maura L. Furey Janssen (Belgium)
Robert B. Innis
Robert B. Innis National Institutes of Health
Chadi G. Abdallah
Chadi G. Abdallah Baylor College of Medicine
Alan Anticevic
Alan Anticevic Yale University
Kelly P. Cosgrove
Kelly P. Cosgrove Yale University
Jonathan P. Roiser
Jonathan P. Roiser University College London
Philip R. Corlett
Philip R. Corlett Yale University
Francis J. McMahon
Francis J. McMahon National Institutes of Health
Lindsay A. Farrer
Lindsay A. Farrer Boston University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience opens doors to a range of related online degrees and flexible career pathways. Many students interested in brain science also consider adjacent fields such as psychology, therapy, and social work for their online studies.

Those seeking a direct clinical route may look into mft masters programs, which prepare graduates to support families and couples through mental health challenges. For a broader approach, a masters in psychology online cheap degree can offer both affordability and flexibility for deepening your understanding of human behavior.

Undergraduate students may want to start with an online degree in psychology, which provides a useful foundation for further specialization, whether in neuroscience or mental health fields. Alternatively, if social advocacy and community empowerment are your goals, an msw degree (Master of Social Work) can be an accessible online pathway.

Together, these related online degrees help students customize their career paths, whether in clinical, research, or social service settings.

Best Scientists Citing Mark J. Niciu

Trending Scientists